-+ 0.00%
-+ 0.00%
-+ 0.00%

LANTERN PHARMA TO ADVANCE EMA-CLEARED PHASE 1B/2 TRIAL OF LP-184 (ZIRDAFULVEN) IN BIOMARKER-SELECTED ADVANCED BLADDER CANCER

Reuters·07/28/2026 11:45:00

Please log in to view news